Autopsy report · NCT01100658

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

“Due to slow accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 6 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Minnesota

Sponsor type

University, hospital or other

Conditions

ALL, Childhood; Leukemia, Lymphoblastic; Leukemia, Lymphoblastic, Acute; Leukemia, Lymphoblastic, Acute, L1; Leukemia, Lymphoblastic, Acute, L2; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Interventions

Methylphenidate; Placebo

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Staging Procedures to Diagnose Malignant Pleural Mesothelioma
  “due to low/slow accrual” (94% match in meaning)
• Safety and Activity of Digoxin With Decitabine in Adult AML and MDS
  “Slow accrual” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.